A blood test to identify several foods or vitamin supplements that children with autism disorder cannot process in the normal way could be available as soon as a year from now, a Madison company says.

NeuroPointDX, a division of Stemina Biomarker Discovery, has identified a group of children with autism who have elevated levels of a particular type of fatty acid.

NeuroPoint is conducting a study to see if reducing consumption of foods such as fatty fish or fish oil supplements will diminish autism symptoms in those children.

If the results are positive, the biomarker will become the first part of a panel that will test children for as many as six or more biomarkers — differences in body chemistry — that Stemina has identified in earlier studies, said Stemina CEO and co-founder Elizabeth Donley. Read the full story here.